Daily Roundup

Netwealth Group has been served with a class action claim related to First Guardian investment options offered through its Superannuation Master Fund. The claim connects to issues the company previously addressed through a court-enforceable undertaking with ASIC and a compensation program that wrapped up in January 2026, which saw Netwealth pay approximately $101 million to affected members. The company says it intends to defend the claim vigorously.

**

Healius is making a strategic move to sharpen its focus on core operations. The healthcare company has agreed to sell its wholly owned subsidiary Agilex Biolabs to Novotech Health Holdings for an enterprise value of A$160 million, with expected cash proceeds of around $155 million. The deal should close during the second half of FY 2027, subject to standard conditions. Healius expects to avoid any tax hit from the transaction and says the sale will unlock shareholder value while allowing the company to concentrate on growing its Pathology business.

**

Tamboran Resources is celebrating a string of operational wins. The company, alongside joint venture partner Daly Waters Energy, has become the first to deliver gas sales from the Beetaloo Basin into the Northern Territory gas network. That's a significant milestone for the region. Tamboran also wrapped up the largest stimulation program ever conducted in the Beetaloo Basin, working through three wells across 178 stages. The Sturt Plateau Compression Facility came in on time and roughly US$9 million under budget, which is always a welcome surprise. Adding to the momentum, Tamboran completed its acquisition of Falcon Oil & Gas in May. As of June 30, the company had US$240 million in cash and expected near-term inflows, positioning it well as it aims to reach plateau production of 40 TJ/d through commissioning and production testing.

**

Microba Life Sciences has appointed Geoffrey Cockerill as Interim Chief Executive Officer while Dr. Luke Reid takes medical leave. Cockerill brings more than 30 years of leadership experience, having held senior roles at Diageo Australia, Lion, and Subway Systems across Australia, New Zealand, and South-East Asia. He's also previously served as CEO of Vitura Health Limited and ATP Science, where he led transformation and growth initiatives. His initial six-month engagement, extendable by mutual agreement, comes with a daily fee of $2,100 (excluding GST) for five days per week.

**

Manuka Resources has wrapped up its Share Purchase Plan, raising A$334,055 through the subscription of 4,772,174 new shares. The SPP closed on September 23, with eligible Australian shareholders offered shares at A$0.07 each and New Zealand shareholders at NZ$0.085 each. The new shares are expected to be issued on September 28 and quoted on the ASX from September 30.